Nicolet Advisory Services LLC Boosts Position in Balchem Co. (NASDAQ:BCPC)

Nicolet Advisory Services LLC grew its holdings in Balchem Co. (NASDAQ:BCPCFree Report) by 6.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,662 shares of the basic materials company’s stock after purchasing an additional 228 shares during the quarter. Nicolet Advisory Services LLC’s holdings in Balchem were worth $626,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of BCPC. Conestoga Capital Advisors LLC lifted its holdings in Balchem by 1.8% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock valued at $206,900,000 after purchasing an additional 20,360 shares in the last quarter. Geneva Capital Management LLC lifted its stake in shares of Balchem by 1.7% during the third quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company’s stock valued at $137,257,000 after buying an additional 12,750 shares during the period. Dimensional Fund Advisors LP boosted its position in Balchem by 0.9% during the second quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after acquiring an additional 5,977 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Balchem by 2.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company’s stock worth $63,707,000 after acquiring an additional 7,562 shares during the period. Finally, Congress Asset Management Co. raised its holdings in Balchem by 12.4% in the 3rd quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock valued at $53,053,000 after acquiring an additional 33,373 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Stock Performance

NASDAQ:BCPC opened at $182.44 on Friday. Balchem Co. has a fifty-two week low of $120.81 and a fifty-two week high of $186.03. The firm’s 50 day moving average is $173.84 and its two-hundred day moving average is $166.54. The company has a market cap of $5.93 billion, a P/E ratio of 49.04, a P/E/G ratio of 5.39 and a beta of 0.65. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.

Analyst Ratings Changes

BCPC has been the topic of several analyst reports. HC Wainwright raised their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Check Out Our Latest Analysis on Balchem

About Balchem

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

See Also

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPCFree Report).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.